In this deeply personal episode, William Scherkenbach shares with host Andrew Stotz what it was like to sit in Deming’s classroom in 1972, join him for late-night chats at the Cosmos Club, and help ignite transformational change at Ford and GM.
Read More
Hong Leong Asia Limited (HLA SP): Profitable Growth rank of 8 was up compared to the prior period’s 9th rank. This is below average performance compared to 1,430 large Industrials companies worldwide.
Read More
LT Group Incorporated (LTG PM): Profitable Growth rank of 8 was same compared to the prior period’s 8th rank. This is below average performance compared to 1,430 large Industrials companies worldwide.
Read More
MC Group Public Company Limited (MC TB): Profitable Growth rank of 3 was down compared to the prior period’s 1st rank. This is above average performance compared to 750 small Cons. Disc. companies worldwide.
Read More
In August 2025, we published 4 new episodes of the My Worst Investment Ever podcast. Listen to all of them here.
Read More
US stocks hit ATH valuation. Trump taking control of the Fed. Fed gives up its inflation target. Trump is going full Xi. US government spending at WW2 levels.
Read More
In this episode of Enrich Your Future, Andrew and Larry Swedroe discuss Larry’s new book, Enrich Your Future: The Keys to Successful Investing. In this series, they conclude the lessons from the book.
Read More
This post shows how KPIs evolved from simple measures to strategy tools. You will see Rockart, the Balanced Scorecard, and OKRs. You will also see how AI in 2025 makes KPIs predictive for investors.
Read More
Discover how Key Performance Indicators evolved from John F. Rockart’s 1979 concept to today’s AI-powered predictive analytics. This comprehensive guide traces the complete history of KPIs—from the Balanced Scorecard revolution to modern OKRs and 2025 investment applications. Learn how early pioneers transformed simple metrics into strategic management tools, and explore how artificial intelligence is reshaping KPIs for investors seeking data-driven insights.
Read More
Tasly Pharmaceutical Group Company Limited (600535 SH): Profitable Growth rank of 6 was down compared to the prior period’s 5th rank. This is below average performance compared to 380 large Health Care companies worldwide.
Read MoreAS SEEN ON:
